Abiopharma

🔍 Franklin Travis (Executive)

Company: Midland States Bancorp, Inc. (MSBI)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 9,400 shares of Common Stock at $26.4881 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: false | shares_owned_after: 9,400.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 9,892 shares of Common Share Equivalent at $22.65 per share (Derivative)
  Date: 2026-05-05 | Code: H | shares_owned_after: 9,891.58 | Footnotes: F2, F2, F2, F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.40 - $26.50 inclusive. The reporting person undertakes to provide to Midland States Bancorp, Inc., any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote.
• F2: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director.
• F3: Each common stock equivalent is the economic equivalent of one share of common stock.